Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Exenatide pegylated analogue - PegBio

Next Previous
Search
Drug Profile

Exenatide pegylated analogue - PegBio

Alternative Names: PB-119; PEG-exenatide; Polyethylene glycol exenatide - PegBio

Latest Information Update: 14 Jun 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator PegBio
  • Class Antidementias; Antiglaucomas; Antihyperglycaemics; Antiparkinsonians; Obesity therapies; Peptides; Venoms
  • Mechanism of Action Glucagon-like peptide-1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Type 2 diabetes mellitus
  • Phase I/II Obesity

Most Recent Events

  • 27 May 2024 Phase-I/II clinical trials in Obesity (In volunteers) in China (SC) (NCT06350812)
  • 05 Apr 2024 PegBio plans a phase I/II trial for Obesity (SC) in May 2024 (NCT06350812),
  • 02 Oct 2023 Efficacy and adverse events data from a phase III trial in Type 2 diabetes mellitus presented at the European Association for the Study of Diabetes (EASD-2023)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top